2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Tredegar Corporation's Board elected Ana Dutra as a director and member of the Executive Compensation Committee, effective immediately, after determining she is independent under NYSE rules. The filing discloses no financial results, and the board addition is an governance change rather than a change to the company's operations.
Board elected Ana Dutra as director on August 17, 2026, effective immediately
Dutra also joined the Board's Executive Compensation Committee
Board determined Dutra is independent under company standards and NYSE rules
Dutra will receive compensation under the existing non-employee director program described in the 2026 proxy statement
First Business Financial Services furnished an investor presentation on its second-quarter 2026 results and strategy. Diluted EPS was $1.84 and net income available to common was $15.4 million, up 28% from the linked quarter and 37% from a year earlier, though Q2 EPS included a $0.14 net one-time benefit. The company also exited out-of-footprint SBA 7(a) lending in May 2026 and estimates a $0.03 quarterly EPS benefit in 2027.
Q2 2026 diluted EPS $1.84 (up 28% linked quarter, up 36% year over year); net income available to common $15.4 million
Q2 EPS included a $0.14 net benefit from a $1.5 million deferred tax asset valuation allowance reversal, partly offset by $405,000 in severance costs
Operating revenue $46.7 million, up 14% year over year for the first half comparison in the table is $91.0 million, up 11%
Out-of-footprint SBA 7(a) lending exit completed in May 2026; estimated 2027 quarterly EPS benefit of $0.03
On August 19, 2026, Amylyx entered an underwriting agreement to sell 14,090,000 new shares of common stock at $35.50 per share, with a 30-day option for underwriters to buy up to 2,113,500 more. Expected net proceeds are about $471.7 million, or about $542.5 million if the option is exercised in full, and the company plans to use them to fund a potential U.S. launch of avexitide if approved, add manufacturing capacity, and for research, working capital and general corporate purposes. The offering is expected to close on August 21, 2026, and the new shares add to the company's outstanding share count.
14,090,000 firm shares offered at $35.50 per share, all sold by the company
Underwriters have a 30-day option to buy up to 2,113,500 additional shares
Expected net proceeds of about $471.7 million, or about $542.5 million if the option is fully exercised
Offering expected to close on August 21, 2026, subject to customary closing conditions
On August 20, 2026, Charter Communications completed its transactions with Cox Communications and its acquisition of Liberty Broadband. Cox Enterprises now owns about 26% of Charter's fully diluted shares, and about $12 billion of Cox debt and finance leases remains outstanding at Charter subsidiaries. Charter's board also changed, with Alex Taylor becoming Chairman and Liberty Broadband no longer a direct shareholder.
Charter paid $3.5 billion in cash to Cox NewCo for the Cox equity sale, and Charter Holdings paid $724 million in cash plus $6.0 billion of convertible preferred units.
Charter issued the equivalent of just over 46 million Charter shares to a subsidiary of Cox Enterprises, and Cox Enterprises now owns about 26% of fully diluted shares.
Liberty Broadband common holders received 0.236 of a Charter Class A share per share, a net decrease of about 4.7 million Charter shares outstanding.
Alex Taylor was appointed Chairman, Eric Zinterhofer became lead independent director, and Chris Winfrey continues as President and CEO.
Coty Inc. said Soraya Benchikh, formerly Chief Financial Officer of British American Tobacco, will succeed Laurent Mercier as Chief Financial Officer effective September 1, 2026, with Mercier serving through August 31, 2026. The company said Mercier's departure is not the result of any disagreement on operations, policies or practices, and the filing also raises Interim Chief Executive Officer Markus Strobel's base salary to $1.6 million from $1.25 million.
Mercier remains CFO through August 31, 2026; Benchikh takes over September 1, 2026.
Benchikh's employment agreement sets annual gross fixed compensation of €1,165,000 and a $2.5 million sign-on RSU award.
Strobel's base salary rises to $1.6 million from $1.25 million, effective September 1, 2026, with target bonus raised to 170% from 150%.
Benchikh will join Coty's Executive Committee and report directly to Strobel, per the press release.
On August 14, 2026, Aptera Motors entered a Strategic Partnership Agreement with Shanghai Launch Automotive Technology under which Launch will provide manufacturing and contract-engineering work. Aptera agreed to pay up to RMB 300 million, with two-thirds of each approved invoice paid in cash up to RMB 200 million and one-third paid through warrants up to RMB 100 million. The filing says the deal could result in additional share issuance to Launch, which may dilute existing shareholders.
Agreement effective August 14, 2026; Launch to perform manufacturing, engineering, tooling and testing under agreed work orders
Initial warrants for 3,369,629 Class B shares, valued at RMB 50 million, issued to Launch on the effective date; not exercisable until credited against approved invoices
Warrants have a five-year term, with exercise prices of $2.20 for initial warrants and at least $2.25 per share for later warrants
Warrants are subject to a 4.99% beneficial ownership limit and a 19.99% exchange cap unless Nasdaq stockholder approval is obtained
Cosmos Health reported second-quarter 2026 revenue of $18.99 million, up 28.8% from a year earlier, and said it was the highest second-quarter revenue in its history. The net loss widened to $6.09 million from $2.83 million, which the company attributed mainly to $2.65 million of non-cash charges, chiefly fair value adjustments on its financing arrangements.
Q2 2026 revenue was $18.99 million, up 28.8% from $14.75 million; first-half revenue was $36.91 million, up 29.7%.
Q2 2026 net loss was $6.09 million, compared with $2.83 million in Q2 2025; first-half net loss was $8.89 million versus $3.65 million.
Q2 2026 gross profit was $1.51 million, up 29.9%; excluding $0.33 million of sales discount reversals, adjusted gross profit was $1.84 million, up 58.4%.
The Board authorized a share repurchase of up to $5.0 million on June 26, 2026; the company has repurchased 5,112,000 shares for about $1.11 million as of this date.
VieMed Healthcare furnished an August 2026 investor presentation under Regulation FD that reports second-quarter 2026 net revenue of $78.1 million, up 24% from a year earlier, and Adjusted EBITDA of $13.7 million. The deck restates full-year 2026 guidance and says the board authorized a new share repurchase program of up to 5% of shares outstanding.
2Q 2026 net revenue was $78.1 million, up 24% year over year; Adjusted EBITDA was $13.7 million.
2026 guidance: net revenue of $314 million to $320 million and Adjusted EBITDA of $64 million to $68 million.
New share repurchase program authorized for up to 5% of shares outstanding; 680,802 shares were bought in 1H 2026 for $6.5 million.
Net debt was effectively zero as of June 30, 2026, with $46 million of unfunded credit facility commitments.
Richmond Mutual Bancorporation, Inc. said its Board declared a cash dividend of $0.15 per share on its common stock. The dividend is payable September 17, 2026, to stockholders of record at the close of business on September 3, 2026. The filing describes the dividend as a continuation of the company's quarterly cash dividend following its merger with The Farmers Bancorp.
Cash dividend of $0.15 per share declared on August 20, 2026
Record date is the close of business on September 3, 2026
Payment date is September 17, 2026
CEO Garry Kleer said the company is pleased to continue its quarterly cash dividend following the completed merger with The Farmers Bancorp
GXO Logistics said its board approved Christina Carvalho as chief accounting officer, effective September 14, 2026, replacing interim chief accounting officer Laura Bracken on that date. The offer letter sets a $475,000 base salary, a 75% target bonus and a $1,000,000 sign-on equity award, which is a leadership change in the finance function rather than a change in company results.
Carvalho, 50, was Senior Vice President and Chief Accounting Officer of Amer Sports Inc. since April 2024.
Offer letter sets base salary at $475,000 and a target annual bonus of 75% of base salary.
Sign-on award of restricted stock units valued at $1,000,000, plus a 2027 annual equity grant target of no less than $400,000.
Laura Bracken ceases to serve as interim chief accounting officer effective September 14, 2026.
American Battery Technology reported preliminary, unaudited results for the quarter ended June 30, 2026, with revenue up 5.1% to $8.2 million and gross profit up 86% to $1.3 million from the prior quarter. The company also warned that a federal directive taking effect August 27, 2026 could block most of its foreign black mass sales, which it says make up the majority of total revenue and could have a material adverse effect.
Q4 FY26 revenue of $8.2 million, up 5.1% from $7.8 million in Q3 FY26
Gross profit of $1.3 million, up 86% from $0.7 million in Q3 FY26; cost of goods sold fell 2.8% to $6.9 million
Department of Commerce directive requires U.S. black mass sellers to allocate 100% of sales to U.S. persons, effective August 27, 2026; public comment period open until November 4, 2026
Company has submitted an exception request to BIS; there is no assurance it will be granted
Rare Earths Americas, Inc. set November 12, 2026 as the date of its 2026 Annual Meeting of Stockholders, its first as a public company, to be held virtually. The Board fixed September 21, 2026 as the record date for stockholders entitled to vote, and set deadlines for shareholder proposals and director nominations.
Annual meeting date set for November 12, 2026, held exclusively online by live webcast
Record date for voting is the close of business on September 21, 2026
Rule 14a-8 proposals due by September 4, 2026; advance notice and universal proxy notices due by August 29, 2026
Icahn Enterprises L.P. completed the previously announced sale of The Pep Boys-Manny, Moe & Jack Holding Corp. to a subsidiary of Mavis for approximately $700 million in cash, subject to customary purchase price adjustments. IEP retains the owned real estate transferred from Pep Boys, along with its AAMCO Transmissions and Precision Tune Auto Care businesses. The filing does not disclose the financial results or gain from the sale.
Buyer: Mavis Tire Supply, LLC, a subsidiary of Mavis Tire Express Services Corp.
Sale price: approximately $700 million in cash, subject to customary purchase price adjustments.
Seller: Icahn Automotive Group LLC, a wholly-owned IEP subsidiary; closed August 20, 2026.
Retained by IEP: owned real estate, AAMCO Transmissions and Precision Tune Auto Care businesses.
RF Acquisition Corp II shareholders voted on August 19, 2026, at an extraordinary general meeting and approved the Business Combination Proposal, which covers the merger with NYB Holdings Limited and the amalgamation with Nanyang Biologics Pte. Ltd. Holders also submitted preliminary requests to redeem 3,956,323 shares for cash from the trust account, and the company says the closing may not occur and the final redemption figures cannot be determined until closing.
Business Combination Proposal: 6,765,584 votes for, 440,604 against, 0 abstentions, out of 7,206,188 shares present (86.36% of 8,343,765 shares entitled to vote)
Preliminary redemption requests for 3,956,323 RFAC ordinary shares, subject to withdrawal or reversal before closing
Closing remains subject to closing conditions and may not occur; final redemption amounts will be disclosed after closing
Other proposals, including the merger, Nasdaq issuance, incentive plan and adjournment, received the same vote counts
Personalis received a new task order under its U.S. Department of Veterans Affairs contract for the Million Veteran Program, valued at up to $18.3 million and effective September 30, 2026. Cumulative task order value under the VA MVP contracts rose to approximately $243.3 million, though the order's value depends on receipt of samples and services performed.
New task order valued at up to $18.3 million, effective September 30, 2026
Task order is subject to receipt of VA MVP samples and performance of services by Personalis
Cumulative value of VA MVP task orders increased to approximately $243.3 million
Cantor Equity Partners I, Inc. (CEPO) and BSTR agreed on August 20, 2026 to terminate their business combination agreement in its entirety, with the parties releasing each other from related claims. Under the Termination and Release Agreement, the seller agreed to pay CEPO an aggregate of $15 million in cash, and CEPO's board will not call a shareholder meeting to approve the deal; CEPO intends to search for another target business.
Seller agreed to pay CEPO $15 million total: $10 million on September 19, 2026 and $5 million on December 1, 2026.
Business Combination Agreement, dated July 16, 2025 and amended March 25, 2026, is of no further force and effect.
Pubco and Newco intend to withdraw the Form S-4 filed May 14, 2026.
Cantor Fitzgerald & Co. engagement letters with CEPO and Pubco were terminated; the Subscription Agreements for private placements also terminated.
Thunder Bridge Capital Partners V, Ltd., a blank check company, completed its initial public offering on August 14, 2026, selling 30,015,000 units at $10.00 each, including the full exercise of the underwriter's over-allotment option, for gross proceeds of $300,150,000. The full amount was placed in a U.S. trust account, and the company has 24 months from closing to complete a business combination, with no target selected as of the filing.
IPO closed August 14, 2026: 26,100,000 units plus 3,915,000 over-allotment units, totaling 30,015,000 units at $10.00 each
Private placement of 747,000 units to the sponsor and Cantor for gross proceeds of approximately $7,470,000
$300,150,000 placed in trust account with Continental Stock Transfer & Trust Company as trustee
Company has not selected a business combination target and has until 24 months after the IPO closing to complete one
Virtus Investment Partners appointed John T. Boyce as a director effective August 19, 2026, and as a member of the Audit Committee. Boyce previously led North America distribution at Insight Investment and Standard Life Investments, a role that the company says brings distribution and operating expertise to its board.
Boyce was appointed effective August 19, 2026, and joins the Audit Committee.
Boyce, 66, served as head of North America distribution for Insight Investment from 2018 to 2023.
He will receive pro rata cash retainer and equity compensation for the remainder of the 2026 board service year.
The filing states there is no arrangement under which Boyce was selected as a director.
On August 20, 2026, James Hardie agreed to sell its European fiber gypsum and cement-bonded products business, including Fermacell, to a subsidiary of Holcim for €840 million, about $980 million. The company expects about $600 million of the proceeds to repay debt and has also authorized a $250 million share repurchase program. The sale is expected to close in the first half of 2027, and the company plans to wind down its European fiber cement operations, which are not included in the sale.
Buyer is Holcim Westbeteiligungs GmbH, a subsidiary of Holcim Ltd., with Holcim Ltd. as guarantor; price is €840 million, subject to net debt and working capital adjustments
About $600 million of proceeds is expected to repay debt, supporting a target of net leverage below 2.0x by September 30, 2027
Board authorized a share repurchase program of up to $250 million; the company is not obligated to buy any shares
Closing expected in the first half of calendar 2027, subject to antitrust approvals and employee consultations; the Purchaser may owe the Sellers a €15 million termination fee in certain circumstances
Devon Energy announced several executive leadership changes effective August 20, 2026, including new Executive Vice Presidents for Exploration & Production and a new Chief Technology Officer. Two former EVPs, John Raines and Michael DeShazer, are leaving the company as of September 1, 2026. The filing does not describe the reasons for the changes or any financial effect, so its direct impact on shareholders is unclear.
Tom Hellman named EVP, Exploration & Production, covering Anadarko, Eagle Ford, Marcellus and Rockies; previously SVP, New Ventures
Robert (Trey) Lowe III named EVP, Exploration & Production, covering Permian; previously EVP and Chief Technology Officer
Kevin Smith named EVP and Chief Technology Officer; previously SVP, Subsurface
John Raines and Michael DeShazer leaving the company as of September 1, 2026
Abbott agreed to resolve the Gill lawsuit and necrotizing enterocolitis claims for about 2,000 other infants for an aggregate of approximately $670 million, instead of continuing its appeal or paying about $600 million on the Gill judgment plus interest. The company states the agreements are a compromise and not an admission of liability, but the payment is a sizable cost, and roughly 1,700 lawsuits involving about 12,700 infants remain pending.
Gill case: July 2024 Missouri jury verdict of $495 million, affirmed by the Missouri Court of Appeals in May 2026.
Settlement: aggregate amount of approximately $670 million covering the Gill case and claims for about 2,000 additional infants.
Alternative cited: paying approximately $600 million, the Gill judgment plus accrued interest to date.
Remaining litigation: roughly 1,700 lawsuits involving claims for about 12,700 individual infants.
Corteva's subsidiary EIDP entered a supplemental indenture on August 20, 2026, that removes most restrictive covenants and events of default from its notes, with the changes taking effect only when Vylor's exchange offers settle alongside the separation. The filing says the amendments were approved by the required majority of noteholders as of August 19, 2026, and would not take effect if the separation is not completed.
On August 20, 2026, EIDP entered a fourth supplemental indenture with U.S. Bank Trust Company as trustee.
The proposed amendments would eliminate substantially all restrictive covenants and events of default, other than payment and bankruptcy-related defaults.
Vylor received the required consents from noteholders as of August 19, 2026; the amendments become operative only at settlement of the exchange offers, expected alongside the separation.
On August 14, 2026, subsidiaries EV Gen Set 1, LLC and EV Gen Set I HoldCo, LLC entered into a senior secured term loan facility of approximately $137.5 million with CSC Delaware Trust Company as agent and a group of lenders. Loans are drawn in installments to pay for power generation equipment and installation services under an Equipment Supply Agreement, and the facility matures on January 2, 2028. For shareholders, this adds $137.5 million of secured debt, with interest rates set to rise after December 31, 2026.
Approximately $137.5 million senior secured term loan dated August 14, 2026, with CSC Delaware Trust Company as administrative and collateral agent
Interest of 6.75% on SOFR loans and 5.75% on ABR loans through December 31, 2026, rising to 7.50% and 6.50% thereafter
Facility matures January 2, 2028; borrower may prepay on three Business Days' notice, subject to accrued interest, breakage costs and a repayment premium
Loans are secured by a first priority interest in substantially all assets of the borrower and Holdings and guaranteed by Holdings; borrower must keep a debt service reserve covering three months of debt service
Abercrombie & Fitch expanded its Board from nine to 10 members on August 18, 2026, and appointed Mary Fox as a non-associate director. Fox is currently president of The Lovesac Company, and her term runs until the 2027 Annual Meeting. The filing does not yet name her Board committee assignments, which the company says it will disclose later.
Board increased from nine to 10 members; Fox appointed effective August 18, 2026
Fox, 54, is President of The Lovesac Company; previously held roles at BIC, L'Oréal and Walmart
Fox's pay follows the non-associate director program described in the April 20, 2026 proxy statement, pro-rated to the 2027 Annual Meeting
Board committee assignments not yet determined; company intends to file an amendment
Royal Caribbean completed a $1.25 billion offering of 5.550% senior notes maturing January 20, 2034, on August 20, 2026. The company expects net proceeds of about $1.24 billion, which it plans to use mainly to repay part of its floating rate term loan borrowings and any remaining amount to repay or refinance other debt.
Principal amount of $1.25 billion of 5.550% senior notes due January 20, 2034
Net proceeds of about $1.24 billion, to repay part of floating rate term loan borrowings and other existing debt
Interest accrues from August 20, 2026 and is paid semi-annually on January 20 and July 20, starting January 20, 2027
At its August 20, 2026 annual meeting, Sono-Tek shareholders elected three directors to serve until the 2028 annual meeting and ratified CBIZ CPAs P.C. as independent auditor for the fiscal year ending February 28, 2027. The filing also furnishes a shareholder meeting presentation as Exhibit 99.1 and lists Item 2.02 results, but the text provided contains no financial figures, so the filing shows no new financial results.
Adeniyi Lawal received 5,009,487 votes for and 134,476 against; Eric Haskell received 4,820,731 for and 323,232 against; Carol O'Donnell received 4,837,468 for and 306,495 against.
Auditor ratification: 11,611,748 votes for, 13,467 against and 2,414 abstentions, with no broker non-votes.
Christopher L. Coccio, R. Stephen Harshbarger, Joseph Riemer and Kirk Warshaw continue as directors; their terms end in August 2027.
A shareholder presentation was given on August 20, 2026 and is attached as Exhibit 99.1.
Beacon Financial Corporation completed the sale of $175 million of 6.25% fixed-to-floating rate subordinated notes due September 1, 2036, on August 20, 2026. The company estimates net proceeds of about $171.8 million, which it plans to use with cash on hand, if needed, to redeem its $75 million 6.0% notes due 2029 and for general corporate purposes, so the transaction changes the company's debt mix rather than its operating results.
$175 million of subordinated notes issued August 20, 2026, maturing September 1, 2036
Fixed 6.25% interest until September 1, 2031, then resets quarterly to Three-Month Term SOFR plus 2.15%
Estimated net proceeds of approximately $171.8 million
$75 million 6.0% notes due 2029 to be redeemed in full on September 15, 2026, at 100% of principal plus accrued interest
New Jersey Natural Gas, a wholly-owned subsidiary of New Jersey Resources, agreed on August 20, 2026 to sell $150 million of senior notes in three series to institutional investors. The Series A and Series B notes, totaling $100 million, closed the same day, and the $50 million Series C notes are expected to close on October 22, 2026. The notes are secured by the subsidiary's first mortgage bonds, and the parent company is not directly or contingently obligated, so the debt sits at the utility subsidiary level.
$50 million 5.43% Series A notes due August 20, 2036, closed August 20, 2026
$50 million 6.04% Series B notes due August 20, 2056, closed August 20, 2026
$50 million 5.43% Series C notes due October 22, 2036, expected to close October 22, 2026
Proceeds are for general corporate purposes, including refinancing short-term debt and funding capital expenditures
Sandra A. Van Trease resigned from the boards of Enterprise Financial Services Corp and its subsidiary Enterprise Bank & Trust, effective August 19, 2026, along with her board committee seats. She had been chairperson of the Nominating and Governance Committee and a member of the Audit, Human Capital and Compensation, and Executive Committees. The filing says her decision was not the result of any disagreement with management or the boards.
Resignation effective August 19, 2026, from the Company and Enterprise Bank & Trust boards
Van Trease chaired the Nominating and Governance Committee
She also served on the Audit, Human Capital and Compensation, and Executive Committees
The filing states the resignation was not due to any disagreement with management or the boards
On August 20, 2026, OneMain Finance Corporation, a subsidiary of OneMain Holdings, issued $600 million of 7.125% senior notes maturing March 15, 2034, under an underwritten public offering. The notes add $600 million of unsecured debt at the subsidiary level, guaranteed by OneMain Holdings, which shareholders may track in the company's overall debt load.
Principal amount: $600 million, issued August 20, 2026 by OneMain Finance Corporation
Interest of 7.125% per year, paid semiannually on March 15 and September 15, starting March 15, 2027
Maturity date March 15, 2034; guaranteed on an unsecured basis by OneMain Holdings, Inc.
Redeemable at make-whole price before August 15, 2029, and at 103.5625% in 2029, 101.7813% in 2030, and 100% from 2031
Ares Acquisition Corporation III, a special purpose acquisition company, said holders of its 39,500,000 units may begin separately trading the Class A ordinary shares and warrants starting August 20, 2026. Units not separated continue to trade on the NYSE as AAC.U, while separated shares and warrants trade as AAC and AAC WS. The change affects trading mechanics only and does not alter the company's business combination plans.
Units sold in the IPO, completed July 1, 2026, can be separated starting August 20, 2026
Each unit consists of one Class A ordinary share and one-tenth of one redeemable warrant
Separated shares trade as AAC and warrants as AAC WS on the NYSE; units remain AAC.U
Holders must ask their brokers to contact Continental Stock Transfer & Trust Company to separate units
LiveRamp's board cut its size from seven directors to six on August 17, 2026, eliminating the seat left open when director Kristi Argyilan resigned on July 17, 2026. The board also redesignated director Vivian Chow to a class whose term expires at the 2028 annual meeting, to keep the classes balanced.
Kristi Argyilan resigned from the board on July 17, 2026; she had served since February 11, 2026.
On August 17, 2026, the board reduced its size from seven directors to six.
Vivian Chow was moved from the class with a 2029 term to the class whose term expires at the 2028 annual meeting, effective August 17, 2026.
The changes followed the company's 2026 special meeting of stockholders held on August 17, 2026.
Newmont's board has appointed Peter David Beaven, a former BHP Group Chief Financial Officer, as an independent director effective September 1, 2026, and he will also join the Audit Committee on the same date. The filing says he will receive standard non-employee director compensation, and it discloses no related-party transactions with the company.
Peter David Beaven appointed independent director effective September 1, 2026
Joins the Audit Committee of the Board on the same date
Previously Group Chief Financial Officer of BHP from 2015 to 2021
Temporarily assumed the role of Chief Executive Officer of Renewable Metals Pty Ltd. as of August 7, 2026
On August 17, 2026, NexPoint Real Estate Finance amended its senior secured loan facility with Mizuho Capital Markets, raising the borrowing limit from $375.0 million to $450.0 million and adding assets as collateral. The company also amended a related total return swap, under which it transferred about $144.3 million of cash collateral to Mizuho and will owe an upfront fee, which means more secured debt and cash tied up in the arrangement for shareholders.
Facility borrowing limit increased from $375.0 million to $450.0 million under the August 17, 2026 amendment
$412.2 million was outstanding under the facility as of August 17, 2026
Variable rate of daily compounded SOFR, with a 2.0% floor, plus 4.0% per annum; matures May 1, 2029, with two optional six-month extensions
About $144.3 million of cash collateral transferred to Mizuho; upfront fee owed; make-whole payments may apply to certain early swap terminations
Suja Life entered an Amended and Restated Credit Agreement on August 20, 2026, with JPMorgan Chase Bank, N.A. as administrative agent, replacing its August 23, 2021 credit agreement. The main change is a lower interest rate, and the company expects its 2026 total interest expense to improve to $18.0 million; the CFO said the deal adds no new debt.
Interest rate is Term SOFR plus 1.75%, 2.00%, or 2.25% per annum, based on the consolidated net leverage ratio
Company expects 2026 total interest expense to improve to $18.0 million
CFO Jeff Pedersen said the transaction does not add debt and reduces the cost of carrying existing debt
Agreement dated August 20, 2026, between indirect subsidiaries and JPMorgan Chase Bank, N.A.
Genworth Financial said Thomas J. McInerney will return from a leave of absence and resume the role of President and Chief Executive Officer effective September 2, 2026. Jerome T. Upton, who has been interim President and CEO, will stop serving in that capacity on the same date and remain Executive Vice President and Chief Financial Officer.
Thomas J. McInerney resumes the President and CEO role effective September 2, 2026
He will resume day-to-day operational responsibilities and serve as principal executive officer
Jerome T. Upton ends his interim CEO role on September 2, 2026 and remains Executive Vice President and CFO
ClearSign Technologies reported second quarter 2026 revenue of about $560,000, up from about $133,000 a year earlier, and a smaller net loss, which fell by $373,000 on lower general and administrative expenses. The company also said it sold 500,000 shares at $3.54 on July 21, 2026, adding about $1.7 million in net proceeds, and that six M1 Series burners were ordered from two midstream customers in West Texas.
Q2 2026 revenue was about $560,000 versus about $133,000 in Q2 2025; gross margin was about 41%, roughly flat year over year.
Net loss decreased by $373,000 year over year, mainly from a $368,000 decrease in general and administrative expenses.
Cash and cash equivalents were about $9.9 million at June 30, 2026; pro forma for the July 21 share sale, about $11.6 million.
Larry Saddler, a retired ExxonMobil executive, was appointed to the Board of Directors.
Edesa Biotech, Inc. priced an underwritten public offering of 3,870,500 common shares and pre-funded warrants for up to 675,000 common shares, each sold with a common share warrant, with gross proceeds expected to be approximately $25.0 million. The company expects net proceeds of approximately $23.1 million, to be used for general corporate purposes, and expects the offering to close on or about August 21, 2026, which adds new shares and warrants that can dilute existing shareholders.
Combined offering price of $5.50 per common share with a warrant, and $5.4999 per pre-funded warrant with a warrant.
Expected net proceeds of approximately $23.1 million; closing expected on or about August 21, 2026.
Warrants have a $7.50 exercise price and expire on the earlier of the 18-month anniversary of issuance or 30 days after public announcement of Phase 2 vitiligo topline data for EB06.
Underwriters hold a 30-day option to buy up to 681,825 additional shares; executive officers and directors agreed to a 90-day lock-up, subject to exceptions.
Primo Brands director Allison Spector resigned from the board after the ORCP Stockholders reduced their ownership of Class A common stock, with the resignation effective August 18, 2026. The company said the departure was not due to any disagreement on operations, policies or practices, and the board reduced its size to ten directors.
Allison Spector resigned from the Board; the resignation became effective upon acceptance by the Unaffiliated Directors on August 18, 2026.
Resignation followed a decrease in ownership of Class A common stock by the ORCP Stockholders, under the Stockholders Agreement dated November 7, 2024.
Board size reduced to ten directors, as agreed by the Initial ORCP Stockholder under the Certificate of Incorporation.
The company stated the resignation was not due to any disagreement with the company.
Dynatrace subsidiary Dynatrace LLC issued $1.4375 billion of 0.00% exchangeable senior notes due September 1, 2031, on August 20, 2026, including the full $187.5 million option. The company also used about $134.7 million of net proceeds to repurchase about 2.83 million shares of its common stock, and terminated its senior secured revolving credit facility. The notes are exchangeable into cash, shares or both, which could dilute shareholders if exchanged into stock, though hedge and warrant transactions are intended to offset part of that dilution.
Notes issued August 20, 2026: $1.4375 billion principal, 0.00% interest, maturing September 1, 2031
Net proceeds of about $1.411 billion; about $167.8 million used for the note hedge cost, net of warrant proceeds
About $134.7 million used to repurchase about 2.83 million shares at $47.61, the August 17, 2026 closing price
Initial exchange price of about $64.27 per share; the revolving credit facility was terminated with only cash-collateralized letters of credit outstanding
Ross Stores reported second-quarter fiscal 2026 sales of $6.3 billion, up 13%, with comparable store sales up 10%. Diluted earnings per share were $2.66 versus $1.56 a year earlier, including an approximate $0.60 benefit from $253 million in IEEPA tariff refunds, and the company raised its third- and fourth-quarter and full-year 2026 earnings per share projections.
Q2 sales $6.3 billion, up 13% from $5.5 billion; comparable store sales up 10%
Diluted EPS $2.66 vs. $1.56 a year ago, including about $0.60 from tariff refunds; prior guidance was $1.85 to $1.93
Fiscal 2026 EPS projection raised to $8.61 to $8.77; Q3 comparable sales guidance 6% to 7%, Q4 4% to 5%
2026 new store plan raised to 115 locations; company remains on track to repurchase $1.275 billion of stock in fiscal 2026
Flowers Foods reported second-quarter results for the 12 weeks ended July 18, 2026, with net sales down 4.0% to $1.193 billion and net income down 30.3% to $40.7 million, or $0.19 per diluted share. The company lowered its full-year 2026 outlook for net sales, adjusted EBITDA and adjusted diluted EPS, citing a more cautious view for the rest of the year. Shareholders face lower expected earnings for 2026 than previously guided.
Net sales fell 4.0% to $1.193 billion, with volume down 5.8% and pricing/mix up 1.8%.
Adjusted EBITDA fell 19.2% to $111.3 million, and adjusted diluted EPS fell $0.09 to $0.21.
Full-year 2026 adjusted diluted EPS guidance was cut to $0.75 to $0.85 from $0.80 to $0.90; net sales guidance was cut to $5.070 billion to $5.142 billion from $5.163 billion to $5.267 billion.
Management will host a live question-and-answer webcast at 8:30 a.m. Eastern Time on August 21, 2026.
Evolution Petroleum agreed on August 18, 2026 to sell 3,700,000 common shares at $3.25 per share, and the underwriters exercised their option in full on August 19 for 555,000 more shares. The company received net proceeds of approximately $12.4 million, and the offering closed on August 20, 2026. The company plans to use the proceeds to help fund a previously announced Permian Basin mineral and royalty acquisition, but the offering is not conditioned on that deal closing.
3,700,000 shares priced at $3.25 per share on August 18, 2026; Roth Capital Partners acted as representative of the underwriters.
Underwriters exercised the 30-day option in full on August 19, 2026, for 555,000 additional shares.
Net proceeds of approximately $12.4 million; the offering closed on August 20, 2026.
Proceeds are intended for part of the Permian Basin acquisition price, credit facility borrowings, cash on hand and general corporate purposes; the company cannot assure the acquisition will be completed.
On August 19, 2026, Ensign Group entered into a Fourth Amended and Restated Credit Agreement with Truist Bank as administrative agent, increasing the revolving facility by $200.0 million to up to $800.0 million and extending maturity to August 19, 2031. The company says the facility provides liquidity for acquisitions, capital investments and general purposes, while the borrowings are secured by certain assets and guaranteed by certain domestic subsidiaries.
Aggregate revolving capacity rises by $200.0 million to up to $800.0 million.
Maturity extended from the prior agreement to August 19, 2031.
Interest is base rate plus 0.25% to 1.00%, or Term SOFR plus 1.25% to 2.00%, based on the leverage ratio; unused commitment fee is 0.175% to 0.30%.
Borrowers' obligations are joint and several, guaranteed by certain domestic subsidiaries and secured by liens on certain assets.
Lifetime Brands entered into a $60.0 million second lien term loan and amended its $200.0 million ABL revolving credit facility, both maturing August 17, 2031. The new term loan repaid its existing term loan B, and the filing says the refinancing extends the company's debt maturities, though the term loan carries margins of 6.75% to 8.25%.
Term Loan: $60.0 million, funded in full on August 17, 2026, maturing August 17, 2031, with quarterly principal payments of 1.25% starting October 1, 2027
Term loan margin: 6.75% to 7.25% over Term SOFR, or 7.75% to 8.25% over base rate, depending on ABL availability
ABL facility: $200.0 million revolving commitments, amended and extended to August 17, 2031, with margins fixed at 1.75% for term benchmark loans through the quarter ending on or about September 30, 2026
Term loan covenant requires Adjusted EBITDA of at least $30.0 million, measured monthly on a trailing twelve-month basis
On August 14, 2026, Werewolf Therapeutics agreed to sell its pre-clinical INDUCER and INDUKINE platform technology to EMD Serono, with EMD paying $28.0 million upfront and an additional $5.0 million upon completion of the technology transfer. The company keeps its WTX-124 and WTX-330 clinical programs and received an exclusive license to certain patents needed to develop them, but it agreed to a 24-month non-competition covenant on certain related compounds.
Upfront consideration of $28.0 million, plus an additional $5.0 million upon completion of the technology transfer
Sold INDUCER and INDUKINE pre-clinical platforms and related compounds, excluding the WTX-124 and WTX-330 clinical programs
Company retains rights to continue developing WTX-124 and WTX-330
Non-competition covenant for 24 months after closing, with customary exceptions for change of control transactions
RenovoRx said Nasdaq confirmed on August 20, 2026 that it has regained compliance with the Nasdaq minimum bid price requirement, and Nasdaq considers the matter closed. The closing bid price was at or above $1.00 per share for the ten consecutive business days from August 6 through August 19, 2026. The filing removes a listing deficiency that had been pending since December 31, 2025, but it reports no financial results or business changes.
Nasdaq notified RenovoRx on December 31, 2025 that its stock had closed below $1.00 for 30 consecutive business days.
Nasdaq confirmed on August 20, 2026 that the closing bid price was $1.00 or greater for ten consecutive business days, August 6 through August 19, 2026.
Nasdaq considers the minimum bid price matter closed; the filing reports no financial results or other business developments.
Veeva Systems said Dan Rizzo will become EVP, Sales, Consulting, and Services effective October 2, 2026, succeeding Thomas D. Schwenger, who is resigning from his role as President and Chief Customer Officer. Schwenger, who has been with Veeva since September 2019, is leaving to become CEO of a long-standing Veeva partner, a change that moves a senior sales and customer leadership role to a new executive.
Dan Rizzo appointed EVP, Sales, Consulting, and Services, effective October 2, 2026
Thomas D. Schwenger resigned on August 18, 2026; resignation effective October 2, 2026
Schwenger had been with Veeva since September 2019, most recently as President and Chief Customer Officer
The filing does not state Rizzo's prior role or compensation terms
Bicycle Therapeutics plc disclosed that Charles Swanton resigned as a Class II director, from all board committees, and from its Clinical Advisory Board, effective immediately, on August 18, 2026. The company said the resignation was for personal reasons and not due to any disagreement over operations, policies or practices, so the change is administrative in nature for shareholders.
Charles Swanton resigned as a Class II director on August 18, 2026, effective immediately
He also resigned from the Board's committees and the Company's Clinical Advisory Board
The filing states the resignation was for personal reasons, not a disagreement with the Company
Merit Medical said it eliminated its Chief Operating Officer position in an August 14, 2026 reorganization and named Sheri Lewis Executive Vice President of Global Operations, effective August 31, 2026. Neil W. Peterson, the former COO, became Senior Advisor and has given notice of resignation for good reason effective March 5, 2027. The filing describes a leadership change in the operations function without any reported financial results.
Sheri Lewis appointed EVP of Global Operations effective August 31, 2026, with a $600,000 base salary and $400,000 signing bonus
Lewis's target annual bonus is 60% of base salary, with a maximum of 200%
Neil W. Peterson's COO title was changed to Senior Advisor; his resignation takes effect March 5, 2027
Lewis's agreement provides a lump sum of two times salary plus bonus average if terminated without cause or for good reason after a change of control
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.